Federal Drive

FDA opens Innovation Pathways

A priority review program for new, breakthrough medical devices is underway. FDA\'s Jonathan Sackner-Bernstein explains how it works.

Federal News Network Staff

February 16, 2011 9:41 am

< a min read

wfedstaff | June 3, 2015 9:13 pm

Download audio

The Food and Drug Administration has taken a step forward in its effort to encourage innovation in medical devices. It recently introduced the creation of the Innovation Pathway, a program that would review new medical technologies. The program is designed in part to encourage manufacturers to invest in developing innovative technology. Joining us with more information is Jonathan Sackner-Bernstein, Associate Director of Technology and Innovation at FDA’s Center for Devices and Radiological Health.

Though the Defense Department managed to go unscathed through the Crowdstrike outage, it remains on the alert

Federal Newscast

The road to electrifying America’s personal vehicles starts with the USPS EV fleet

Management

Congress tackles spending, policy and candidate protections on the road to the August recess

Congress

FDA opens Innovation Pathways

Though the Defense Department managed to go unscathed through the Crowdstrike outage, it remains on the alert

The road to electrifying America’s personal vehicles starts with the USPS EV fleet

Congress tackles spending, policy and candidate protections on the road to the August recess

Top Stories